|
|
||||||||
Articles |
1
The Rogosin Institute and Department of Biochemistry, The New York HospitalCornell Medical Center, 505 East 70th St., New York, NY 10021.
2
The Dorrance H. Hamilton Research Laboratories, Division
of Endocrinology, Diabetes, and Metabolic Diseases, Department of
Medicine, Jefferson Medical College of Thomas Jefferson University,
1020 Locust St., Suite 349, Philadelphia, PA 19107-6799.
a Author for correspondence. Fax 212-327-7331; e-mail dmlevine{at}mail.med.cornell.edu
Although mice are commonly used for studies of atherosclerosis, investigators have had no convenient way to quantify apolipoprotein (apo) B, the major protein of atherogenic lipoproteins, in this model. We now report an automated immunoturbidimetric assay for mouse apo B with an NCCLS imprecision study CV <5%. Added hemoglobin up to 50 g/L did not interfere with the assay, nor did one freezethaw cycle of serum samples. Assay linearity extends to apo B concentrations of 325 mg/L. We have used the assay to determine serum apo B concentrations under several atherogenic conditions, including the apo E "knock-out" genotype and treatment with a high-cholesterol diet. Our assay can be used to survey inbred mouse strains for variants in apo B concentration or regulation. Moreover, the mouse can now be used as a convenient small-animal model to screen compounds that may lower apo B concentrations.
Key Words: indexing terms: animal models of disease apo E LDL receptor diet, effects of lipoproteins mice, transgenic
The following articles in journals at HighWire Press have cited this article:
![]() |
S. Marathe, Y. Choi, A. R. Leventhal, and I. Tabas Sphingomyelinase Converts Lipoproteins From Apolipoprotein E Knockout Mice Into Potent Inducers of Macrophage Foam Cell Formation Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2607 - 2613. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Williams, R. Scalia, K. D. Mazany, W. V. Rodrigueza, and A. M. Lefer Rapid Restoration of Normal Endothelial Functions in Genetically Hyperlipidemic Mice by a Synthetic Mediator of Reverse Lipid Transport Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1033 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Escola-Gil, O. Jorba, J. Julve-Gil, F. Gonzalez-Sastre, J. Ordonez-Llanos, and F. Blanco-Vaca Pitfalls of Direct HDL-Cholesterol Measurements in Mouse Models of Hyperlipidemia and Atherosclerosis Clin. Chem., September 1, 1999; 45(9): 1567 - 1569. [Full Text] [PDF] |
||||
![]() |
J.-L. Mu, J. K. Naggert, K. L. Svenson, G. B. Collin, J. H. Kim, C. McFarland, P. M. Nishina, D. M. Levine, K. J. Williams, and B. Paigen Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J J. Lipid Res., July 1, 1999; 40(7): 1328 - 1335. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |